Enfermedad pulmonar intersticial fibrosante progresiva (EPI-FP)
Estimating long-term survival in progressive fibrosing interstitial lung disease (PF-ILD) other than IPF using matched IPF data
Maher T et al.
Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON
Wuyts WA et al.
Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?
Wijsenbeek MS et al.
Association between monocyte count and ILD progression in subjects with fibrosing ILDs: data from the INBUILD trial
Kreuter M et al.
Safety and tolerability of nintedanib in patients with fibrosing interstitial lung diseases (ILDs): pooled data from four trials
Valenzuela C et al.
SC-ES-07047